Non-invasive ventilation with pursed lips breathing mode for patients with COPD and hypercapnic respiratory failure: A retrospective analysis
Open Access
- 21 September 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (9), e0238619
- https://doi.org/10.1371/journal.pone.0238619
Abstract
Long-term non-invasive ventilation (NIV) is recommended for patients with stable chronic obstructive lung disease (COPD) and chronic hypercapnia. High inspiratory pressure NIV (hiNIV) and a significant reduction of arterial pCO2 have been shown to prolong survival. Often, patients on hiNIV describe severe respiratory distress, known as “deventilation syndrome”, after removal of the NIV mask in the morning. Mechanical pursed lips breathing ventilation (PLBV) is a new non-invasive ventilation mode that mimics the pressure-curve of pursed lips breathing during expiration. The clinical impact of switching patients from standard NIV to PLBV has not been studied so far. In this hypothesis generating study, we retrospectively analysed the effects of switching COPD patients (stage GOLD III-IV) from conventional NIV to PLBV. Medical records of all patients who had an established NIV and were switched to PLBV between March 2016 and October 2017 were screened. Patients were included if they complained of shortness of breath on mask removal, used their conventional NIV regularly, and had a documented complete diagnostic workup including lung function testing, blood gas analysis and 6-minute walk test (6MWT) before and after 3–7 days of PLBV. Six male and 10 female patients (median age 65.4 years; IQR 64.0–71.3) with a previous NIV treatment duration of 38 months (median; IQR 20–42) were analysed. After PLVB initiation, the median inspiratory ventilation pressure needed to maintain the capillary pre-switch pCO2 level was reduced from 19.5 mbar (IQR 16.0–26.0) to 13.8 mbar (IQR 12.5–14.9; p1 and residual volume (RV) were non-significant. Based on this small retrospective analysis, we hypothesise that switching patients with COPD GOLD III-IV and chronic hypercapnia from conventional NIV to PLBV may increase exercise tolerance and FVC in the short term.Funding Information
- Leibniz-Gemeinschaft (Open Access Publikationsfonds)
This publication has 13 references indexed in Scilit:
- Hypercapnic COPD patients and NIV at home: is there any benefit? Using the CAT and BODE index in an effort to prove benefits of NIV in these patientsInternational Journal of Chronic Obstructive Pulmonary Disease, 2018
- Non-invasive positive pressure ventilation for the treatment of severe stable chronic obstructive pulmonary disease: a prospective, multicentre, randomised, controlled clinical trialThe Lancet Respiratory Medicine, 2014
- Deventilation syndrome in severe COPD patients during long-term noninvasive mechanical ventilation: poor sleep pattern, hyperinflation, or silent chronic muscular fatigue?Sleep and Breathing, 2014
- Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: A randomized controlled trialRespiratory Research, 2011
- High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trialThorax, 2010
- Noninvasive mechanical ventilation in chronic respiratory failure: ventilators and interfacesPublished by European Respiratory Society (ERS) ,2008
- Weight gain in cachectic COPD patients receiving noninvasive positive-pressure ventilation.2006
- Measurement of air trapping, intrinsic positive end-expiratory pressure, and dynamic hyperinflation in mechanically ventilated patients.2005
- The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patientsEuropean Respiratory Journal, 2002
- Nasal pressure support ventilation plus oxygen compared with oxygen therapy alone in hypercapnic COPD.American Journal of Respiratory and Critical Care Medicine, 1995